NCT06977438View on ClinicalTrials.gov

Promoting Healthy Children and Youth

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

1,020

Participants

Timeline

Start Date

January 1, 2026

Primary Completion Date

January 31, 2030

Study Completion Date

January 31, 2031

Conditions

Obesity, Childhood

Interventions

DRUG

Semaglutide

All participants in this study will receive treatment with Semaglutide

All Listed Sponsors

lead

University of Minnesota

OTHER